InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Acumen Pharmaceuticals, Inc.

ABOS Clue Score27
United States Fiscal year ends December CIK 0001576885 Results filed 26 Oct 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

9
Insider
Date
Role
Action
Shares
Price
Amount
Ra Capital Management, L.p.
21 Jul 2023
Director
Buy indirect
5,161,290
$7.75
$40.00M
Ra Capital Management, L.p.
6 Jul 2021
Director
Buy indirect
115,668
$16.00
$1.85M
Ra Capital Management, L.p.
6 Jul 2021
Director
Buy indirect
1,759,332
$16.00
$28.15M
Sands Capital Ventures Discovery Fund III, L.P.
6 Jul 2021
10% owner
Buy
450,000
$14.88
$6.70M
Nathan B Fountain
6 Jul 2021
Director
Buy
6,250
$16.00
$100.00K
Robert D. Hardie
6 Jul 2021
10% owner
Buy indirect
750,000
$16.00
$12.00M
Robert D. Hardie
6 Jul 2021
10% owner
Buy indirect
312,500
$16.00
$5.00M
John A Stalfort III
6 Jul 2021
Director
Buy
35,000
$16.00
$560.00K
Paul B Manning
6 Jul 2021
10% owner
Buy indirect
312,500
$16.00
$5.00M
Show all 78 transactions →

What was left out

Form 4 filings counted 120
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 9
Sales on a Rule 10b5-1 plan 16
Sales straight out of an exercise 8
Sales at will 42
Transactions with no price 0
Shares from compensation/vesting 30,618,063
History held since 2 Jul 2021